Literature DB >> 28953835

Psychiatric Comorbidity in Older Adults with Intellectual Disability.

Agnieszka Bratek1, Krzysztof Krysta, Krzysztof Kucia.   

Abstract

BACKGROUND: The population of older adults with intellectual disability (ID) is large and growing due to a significant increase of life expectancy caused by improvements in health and social care. Multimorbidity is highly prevalent in this population and co-morbid psychiatric disorders are especially frequent. SUBJECT AND METHODS: The aim of this article is to review the prevalence and consequences of psychiatric comorbidity in the population of older adults with ID. We therefore performed a literature search of studies relevant to adults with ID, published since January 2006, using the following keywords: intellectual disability and comorbidity, intellectual disability and mental disorders, intellectual disability and polypharmacy.
RESULTS: Psychiatric comorbidity is frequent among patients with ID and correlates with older age. Mental disorders are present in up to 40% of older adults with ID and the most prevalent are challenging behaviour, depression, anxiety and dementia. Patients with ID and at least one co-morbid mental disorder are at a high risk of polypharmacy. Importantly, psychiatric comorbidity was found to significantly increase service use and costs of care.
CONCLUSIONS: Further investigation of the population of older adults with ID is needed, with special attention to development of clear treatment guidelines in order to effectively manage co-morbid mental illnesses and physical health problems.

Entities:  

Mesh:

Year:  2017        PMID: 28953835

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  5 in total

1.  The occurrence of comorbidities with affective and anxiety disorders among older people with intellectual disability compared with the general population: a register study.

Authors:  Nadia El Mrayyan; Jonas Eberhard; Gerd Ahlström
Journal:  BMC Psychiatry       Date:  2019-06-03       Impact factor: 3.630

2.  Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors.

Authors:  Laura García-Domínguez; Patricia Navas; Miguel Ángel Verdugo; Víctor B Arias; Laura E Gómez
Journal:  J Appl Res Intellect Disabil       Date:  2022-04-05

3.  Next-generation gene panel testing in adolescents and adults in a medical neuropsychiatric genetics clinic.

Authors:  Y Trakadis; A Accogli; B Qi; D Bloom; R Joober; E Levy; K Tabbane
Journal:  Neurogenetics       Date:  2021-08-07       Impact factor: 2.660

4.  Specialist psychiatric health care utilization among older people with intellectual disability - predictors and comparisons with the general population: a national register study.

Authors:  G Ahlström; A Axmon; M Sandberg; J Hultqvist
Journal:  BMC Psychiatry       Date:  2020-02-17       Impact factor: 3.630

5.  Use of Charlson Comorbidity Index and Nomogram to Predict Mortality in Elderly Patients with Late-Life Schizophrenia.

Authors:  Mei-Chi Hsu; Shang-Chi Lee; Wen-Chen Ouyang
Journal:  Healthcare (Basel)       Date:  2021-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.